A retrospective study gauging the benefit of PET/CT after first-line therapy for follicular lymphoma in multi-center trials puts PET/CT on a pedestal above CT alone as a tool for gauging patients’ response to therapy and prospective survival, according to a study published Sept. 18 in The Lancet Haematology . {read more here}